Related Experiment Video
Updated: Jun 23, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Chronic obstructive pulmonary disease: evidence for an autoimmune component
Anna M Stefanska1, Patrick T Walsh
1School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
Cellular & Molecular Immunology
|May 1, 2009
Summary
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition. Emerging evidence suggests autoimmune responses may drive COPD, offering new therapeutic targets beyond symptom relief.
Area of Science:
- Pulmonology
- Immunology
- Pathology
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health issue, characterized by airflow limitation, inflammation, and lung tissue destruction.
- Current treatments primarily manage symptoms, as underlying disease mechanisms, particularly those driven by tobacco smoke, are not fully understood.
- The traditional view implicates protease-antiprotease imbalance, but complex autoimmune mechanisms are increasingly recognized.
Purpose of the Study:
- To review current evidence supporting an autoimmune paradigm in COPD pathogenesis.
- To explore how understanding these autoimmune aspects can inform future therapeutic strategies.
Main Methods:
- Literature review and synthesis of existing research on COPD mechanisms.
- Analysis of evidence linking autoimmune responses to COPD pathology.
Main Results:
- Growing evidence suggests COPD shares characteristics with classical autoimmune diseases.
- This autoimmune perspective challenges the traditional protease-antiprotease imbalance model.
Conclusions:
- COPD pathogenesis is complex, involving potential autoimmune components.
- Targeting autoimmune pathways may offer novel therapeutic avenues for COPD treatment.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...